ArticleBMC immunology2023

The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device.

Kengo Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.